SG Americas Securities LLC Has $363,000 Stock Holdings in Iradimed Corporation (NASDAQ:IRMD)

SG Americas Securities LLC increased its stake in shares of Iradimed Corporation (NASDAQ:IRMD) by 125.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,595 shares of the medical equipment provider’s stock after purchasing an additional 3,664 shares during the quarter. SG Americas Securities LLC owned approximately 0.05% of Iradimed worth $363,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Huntington National Bank grew its stake in Iradimed by 51.3% in the 3rd quarter. Huntington National Bank now owns 1,487 shares of the medical equipment provider’s stock worth $75,000 after buying an additional 504 shares in the last quarter. Gladius Capital Management LP increased its position in Iradimed by 126.6% during the 3rd quarter. Gladius Capital Management LP now owns 1,727 shares of the medical equipment provider’s stock valued at $87,000 after purchasing an additional 965 shares during the period. Quantbot Technologies LP grew its position in Iradimed by 83.0% during the 3rd quarter. Quantbot Technologies LP now owns 2,320 shares of the medical equipment provider’s stock valued at $117,000 after purchasing an additional 1,052 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in Iradimed during the 3rd quarter valued at about $126,000. Finally, Principal Financial Group Inc. bought a new position in shares of Iradimed in the 3rd quarter worth approximately $246,000. 92.34% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded Iradimed from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, January 28th.

Iradimed Stock Performance

IRMD opened at $59.35 on Tuesday. Iradimed Corporation has a one year low of $40.18 and a one year high of $61.24. The company has a market cap of $751.96 million, a price-to-earnings ratio of 40.65 and a beta of 0.82. The business’s fifty day moving average is $56.13 and its two-hundred day moving average is $51.36.

Insider Activity

In other news, CFO John Glenn sold 2,500 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $54.18, for a total transaction of $135,450.00. Following the completion of the sale, the chief financial officer now directly owns 4,383 shares of the company’s stock, valued at $237,470.94. This trade represents a 36.32 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 37.10% of the company’s stock.

About Iradimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.